BioLabs at Pegasus Park

Secretome Therapeutics Closes $20.4M Financing Round to Advance Heart Therapies

by | Dec 9, 2024
Baltimore-based Secretome—which has a presence at BioLabs at Pegasus Park in Dallas and offices in Plano—said the financing will enable it to initiate clinical trials for its lead asset, STM-01, and further advance its drug development pipeline.
MORE
American Cancer Society’s BrightEdge Golden Ticket Pitch Competition to Be Held at Pegasus Park
by | Oct 24, 2024
Oncology companies seeking seed-stage through Series A funding are invited to apply to the Golden Ticket Pitch Competition, which will be held on March 11, 2025.
MORE
Dallas’ Pegasus Park Expands with New Bridge Labs to Support Biotech Growth
According to an economic impact report by The Perryman Group, the 26-acre Pegasus Park campus, once fully built out under its master plan, is projected to generate $1.9 billion in annual gross product and create over 15,000 jobs.

Bridge Labs, the latest addition to the Pegasus Park campus, is designed to provide high-quality, flexible lab and office space for growth-stage biotech companies. "It's one-of-a-kind in the region," said Nicole Small, CEO of Lyda Hill Philanthropies.
MORE
Dallas-Based HEST Investments Leads $1.8M SPV Investment in Secretome Therapeutics
by | Sep 17, 2024
Baltimore-based Secretome has a presence at BioLabs at Pegasus Park in Dallas. The biotech company is at the forefront of developing "revolutionary solutions" aimed at harnessing the power of secretomes, naturally occurring molecules that promote healing and regeneration, HEST said.
MORE

Bridge Labs Expansion Coming to Pegagus Park in 2024

by | Feb 13, 2023
The new two-story lab and office building will offer "the first institutional-quality space" in the DFW market, according to marketing materials.
MORE
Startup to Storefront: SkinStasis Launches ‘Revolutionary’ Skin Care Product Out of BioLabs at Pegasus Park
Co-founders Paul Stewart and Frank Murdock started up SkinStasis Skin Care earlier this year to meet "a big unmet need" in the cold sore/herpes virus field, where they say there's been "no real new pharmaceutical development" for over 20 years.

Working out of BioLabs at Pegasus Park, they teamed up with Irving's Cosmetic Laboratories to launch NextLeap—which uses tranexamic acid to shorten the time to recovery of normal appearance to as little as 24 to 48 hours, the co-founders say.
MORE